Belite Bio (BLTE) SEC Filings & 10K Form

$42.50
-0.30 (-0.70%)
(As of 05:21 PM ET)

Recent Belite Bio SEC Filings

DateFilerForm TypeView
04/29/2024
12:37 PM
Belite Bio (Filer)
Form 424B5
04/25/2024
8:02 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:26 AM
Belite Bio (Subject)
Chen Wan-Shan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
2:58 PM
Belite Bio (Subject)
MATA NATHAN L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
7:51 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
8:05 PM
Belite Bio (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/11/2024
8:59 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
8:08 PM
Belite Bio (Subject)
Lin Yu-Hsin (Filed by)
Form SC 13G
02/12/2024
7:40 PM
Belite Bio (Subject)
Lin Bioscience International Ltd. (Filed by)
Form SC 13G
12/28/2023
3:15 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/28/2023
3:16 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:36 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/16/2023
3:41 PM
Belite Bio (Subject)
Chuang Hao-Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
7:00 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2023
11:08 AM
Belite Bio (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/31/2023
4:16 PM
Belite Bio (Subject)
Lin Yu-Hsin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:06 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/24/2023
5:07 AM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2023
3:32 PM
Belite Bio (Filer)
Form 424B5
06/16/2023
3:36 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
8:55 PM
Belite Bio (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/30/2023
11:15 PM
Belite Bio (Filer)
Form EFFECT
05/09/2023
11:15 PM
Belite Bio (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BLTE) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners